Ensuring sustained adherence to endocrine therapy is critical for improving outcomes for hormone receptor-positive (HR+) breast cancer patients. Join us for an expert-led discussion on individualizing HR+ breast cancer care. In this on-demand video activity, hear two breast cancer experts review insights and lessons learned from a quality improvement initiative, and discuss strategies for improving adherence, persistence, and tolerability to endocrine therapies to improve outcomes for HR+ breast cancer patients. Download our Shared Decision-Making Guide and use it with your own patients to increase patient knowledge and engagement, tackle potential adverse effects, and address any concerns the patient may have about premature menopause related to ovarian function suppression. Check out the Mock Clinical Consultation to see how to integrate the SDM Guide into practice.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/expert-strategies-improve-endocrine-therapy-adherence-hr-breast-cancer
- Start Date: 2024-03-29 05:00:00
- End Date: 2024-03-29 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Tersera Therapeutics - Amount: 100000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all